In particular, in atherosclerosis and myocardial infarction models, the use of siCCR2 and CCR2 KO mice resulted in a smaller necrotic area and delayed debris clearance with no occurrence of regression (28, 38, 39). This evidence concerns the gene CCR2 and atherosclerosis.